Synergy CHC Corp. (NASDAQ: SNYR), a leading consumer health and wellness company, announced multiple expansion milestones as its flagship FOCUSfactor® Focus + Energy beverage rollout accelerates across the U.S. and…
As the “Magnificent 7” continue to dominate headlines, a new group of micro-cap contenders—dubbed the “Mag 7 Undercard”—is catching the attention of high-risk, high-reward traders. Trading under $1, these stocks…
Synergy CHC Corp. (NASDAQ: SNYR) “Focusfactor” a leading consumer health and wellness company, today announced a series of major milestones that underscore its accelerating national and international expansion, strong financial…
Roadzen Inc. (NASDAQ: RDZN), a global leader in artificial intelligence at the intersection of insurance and mobility, has unveiled a series of transformative milestones solidifying its position as one of…
Kartoon Studios’ (NYSE: TOON) expansion comes as the global entertainment industry undergoes sweeping consolidation. Warner Bros. Discovery (NASDAQ: WBD) faces multiple takeover bids, including one from Paramount Skydance Corporation (NASDAQ:…
The “Mag 7 Undercard” continues to capture investor attention as a wave of emerging growth companies post strategic milestones and operational turnarounds across AI, biotech, media, and consumer wellness sectors.…
Power Metallic Mines Inc. (TSXV: PNPN | OTCQB: PNPNF) announced additional high-grade copper assay results from its summer drilling program at the Nisk Project in Quebec, alongside updates on land…
Specificity Inc. (OTCQB: SPTY), the fast-scaling ad tech disruptor redefining digital marketing precision, today announced that its Form S-1 Registration Statement, initially filed with the U.S. Securities and Exchange Commission…
Datavault AI Inc. (NASDAQ: DVLT) has entered into a groundbreaking agreement with Scilex Holding Company (NASDAQ: SCLX), granting Scilex a worldwide exclusive license—with rights to sublicense—its proprietary AI-driven data tokenization…
Aprea Therapeutics, Inc. (Nasdaq: APRE) is a clinical-stage biopharmaceutical company pioneering a new era in precision oncology. By combining deep genetic insight with targeted molecular design, Aprea is advancing therapies…
